The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Some of the singers lost children in the Aberfan disaster. They perform as a way of coping with their grief and to raise money for charity.
Traffic on the M4 from Coryton to Cardiff is at a standstill following a multiple vehicle crash.
The ex-footballer, who lives in Flintshire, said he thought he was clever sheltering his car from the snow.